Effect of using metformin on the incidence of gestational diabetes and preeclampsia in pregnant women with polycystic ovary
Phase 3
Recruiting
- Conditions
- Condition 1: Gestational diabetes. Condition 2: Pre-eclampsia.Gestational diabetes mellitus in pregnancyPre-eclampsiaO24.41
- Registration Number
- IRCT20120215009014N252
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 170
Inclusion Criteria
Age of 18 to 40 years;
Pregnant;
Polycystic ovary
Exclusion Criteria
A history of repeated abortion;
Uterine abnormality;
A history of chronic disease such as lupus and renal failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the gestational diabetes. Timepoint: Every 3 months until end of pregnancy. Method of measurement: Through laboratory diagnostic test measuring blood glucose.;Assessing the preeclampsia. Timepoint: Every 2 weeks until end of pregnancy. Method of measurement: By physical examination.
- Secondary Outcome Measures
Name Time Method